At 1 to 1.5 years, retatrutide was ranked highest (SUCRA 0.99) and outperformed all currently marketed agents, achieving 3.2% greater weight loss than tirzepatide
In June 2026 the MHRA approved the Wegovy pill (oral semaglutide), the first oral GLP-1 medicine licensed in the UK for weight management
Sales of Ozempic were up by 28 percent in Q3 of 2022, driven by high demand for GLP-1-based diabetes treatments
It's still under trial, and I hope it's as amazing as it looksMedipeelApril 29, 2026I love the packaging and the milky white color of the serum
Most people notice appetite suppression within the first 23 weeks, which directly impacts eating patterns and portion sizes
By offering science-backed services and personalized care, we give patients the gift that keeps givingconfidence